Abstract
Developing novel multifunctional nanoparticles (NPs) with robust preparation, low cost, high stability, and flexible functionalizability is highly desirable. This study provides an innovative platform, termed unibody core-shell (UCS), for this purpose. UCS is comprised of two covalent-bonded polymers differed only by the functional groups at the core and the shell. By conjugating Gd3+ at the stable core and encapsulating doxorubicin (Dox) at the shell in a pH-sensitive manner, we developed a theranostic NPs (UCS-Gd-Dox) that achieved a selective drug release (75% difference between pH 7.4 and 5.5) and MR imaging (r1=0.9 and 14.5mm-1s-1 at pH 7.4 and 5.5, respectively). The anti-cancer effect of UCS-Gd-Dox is significantly better than free Dox in tumor-bearing mouse models, presumably due to enhanced permeability and retention effect and pH-triggered release. To the best of our knowledge, this is the simplest approach to obtain the theranostic NPs with Gd-conjugation and Dox doping.
Original language | English |
---|---|
Pages (from-to) | 436-446 |
Number of pages | 11 |
Journal | Biomaterials |
Volume | 37 |
DOIs | |
State | Published - 01 01 2015 |
Externally published | Yes |
Bibliographical note
Publisher Copyright:© 2014 Elsevier Ltd.
Keywords
- Core-shell
- Drug delivery
- Magnetic resonance imaging (MRI)
- Nanoparticle